Nathalie Dournon

2.4k total citations
12 papers, 41 citations indexed

About

Nathalie Dournon is a scholar working on Infectious Diseases, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nathalie Dournon has authored 12 papers receiving a total of 41 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Surgery and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nathalie Dournon's work include Infectious Diseases and Tuberculosis (3 papers), Travel-related health issues (2 papers) and Tuberculosis Research and Epidemiology (2 papers). Nathalie Dournon is often cited by papers focused on Infectious Diseases and Tuberculosis (3 papers), Travel-related health issues (2 papers) and Tuberculosis Research and Epidemiology (2 papers). Nathalie Dournon collaborates with scholars based in France, Guadeloupe and French Guiana. Nathalie Dournon's co-authors include Stéphane Jauréguiberry, Éric Caumes, Matthieu Revest, Éric Caumes, Clara Duran, Pierre Buffet, Vincent Jarlier, Jean‐Louis Herrmann, Christine Bernard and Nicolas Véziris and has published in prestigious journals such as Emerging infectious diseases, American Journal of Tropical Medicine and Hygiene and Antibiotics.

In The Last Decade

Nathalie Dournon

10 papers receiving 40 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Dournon France 5 19 15 11 5 4 12 41
Shingo Adachi Japan 4 15 0.8× 18 1.2× 12 1.1× 4 0.8× 5 43
Michelle Venter South Africa 3 15 0.8× 6 0.4× 9 0.8× 6 1.2× 2 0.5× 11 24
Deborah Langat United States 4 22 1.2× 20 1.3× 10 0.9× 8 1.6× 2 0.5× 6 35
Daniel Jarovsky Brazil 5 7 0.4× 41 2.7× 6 0.5× 5 1.0× 4 1.0× 17 55
María Penín Spain 3 23 1.2× 14 0.9× 14 1.3× 6 1.2× 5 37
Gabriel Bedoya‐Berrío Colombia 4 21 1.1× 22 1.5× 11 1.0× 4 0.8× 2 0.5× 8 46
K Blechova Czechia 2 12 0.6× 22 1.5× 12 1.1× 7 1.4× 4 24
Sarah M. Labuda United States 4 16 0.8× 15 1.0× 6 0.5× 5 1.0× 10 27
Ayhan Yaman Türkiye 4 32 1.7× 27 1.8× 8 0.7× 5 1.0× 1 0.3× 10 53
C. Tulane France 2 14 0.7× 29 1.9× 14 1.3× 4 0.8× 4 36

Countries citing papers authored by Nathalie Dournon

Since Specialization
Citations

This map shows the geographic impact of Nathalie Dournon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Dournon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Dournon more than expected).

Fields of papers citing papers by Nathalie Dournon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Dournon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Dournon. The network helps show where Nathalie Dournon may publish in the future.

Co-authorship network of co-authors of Nathalie Dournon

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Dournon. A scholar is included among the top collaborators of Nathalie Dournon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Dournon. Nathalie Dournon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Dournon, Nathalie, et al.. (2025). Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview. Antibiotics. 14(3). 277–277. 2 indexed citations
2.
Dournon, Nathalie, et al.. (2025). Treatment Duration in Bacterial Prosthetic Joint Infections: A Narrative Review of Current Evidence. Antibiotics. 14(11). 1066–1066.
3.
Greffe, S., et al.. (2023). MPOX de 1960 à 2022. Du Monkeypox au Mpox. 4(4). 294–301.
4.
Dinh, Aurélien, Frédérique Bouchand, Nathalie Dournon, et al.. (2023). Short Antibiotic Treatment Duration for Osteomyelitis Complicating Pressure Ulcers: A Quasi-experimental Study. Open Forum Infectious Diseases. 10(3). ofad088–ofad088. 5 indexed citations
5.
Dournon, Nathalie, Christine Lawrence, Latifa Noussair, et al.. (2022). Non-Legionella pneumophila serogroup 1 pneumonia: Diagnosis of a nosocomial legionellosis with the Biofire Pneumonia plus panel. IDCases. 28. e01487–e01487. 3 indexed citations
6.
Comparon, Céline, Marouane Boubaya, Nathalie Dournon, et al.. (2021). A short course of corticosteroids reduces the risk of mechanical ventilation and death in patients with moderate to severe COVID 19 pneumonia: results of a retrospective monocentric cohort. Infectious Diseases. 53(10). 779–788. 2 indexed citations
7.
Lefèvre, Benjamin, Thierry Blanchon, Pauline Saint‐Martin, et al.. (2020). Evaluation of a web-based self-reporting method for monitoring international passengers returning from an area of emerging infection. Infectious Diseases Now. 51(2). 140–145. 2 indexed citations
8.
Abboud, Philippe, et al.. (2019). Analyse rétrospective des épidémies d’arbovirus du XIXe siècle : alors dengue ou chikungunya ?. Médecine et Maladies Infectieuses. 49(4). S120–S121. 1 indexed citations
9.
Véziris, Nicolas, Wladimir Sougakoff, Nathalie Dournon, et al.. (2016). XDR-tuberculosis in France: Community transmission due to non-compliance with isolation precautions. Médecine et Maladies Infectieuses. 46(1). 52–55. 9 indexed citations
10.
Henry, Benoît, Matthieu Revest, Nathalie Dournon, et al.. (2015). Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014. Emerging infectious diseases. 22(3). 518–521. 8 indexed citations
11.
Dournon, Nathalie, Pierre Buffet, Éric Caumes, Bernard Clair, & Stéphane Jauréguiberry. (2012). Artesunate for Severe Acute Plasmodium falciparum Infection in a Patient with Myasthenia Gravis. American Journal of Tropical Medicine and Hygiene. 87(3). 435–436. 5 indexed citations
12.
Dournon, Nathalie, et al.. (2012). Seroconversion of Neurocysticercosis Occurring After Anti‐Helminthic Treatment. Journal of Travel Medicine. 19(6). 383–386. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shingo Adachi Breakdown of academic impact, for papers by Michelle Venter Breakdown of academic impact, for papers by Deborah Langat Breakdown of academic impact, for papers by Daniel Jarovsky Breakdown of academic impact, for papers by María Penín Breakdown of academic impact, for papers by Gabriel Bedoya‐Berrío Breakdown of academic impact, for papers by K Blechova Breakdown of academic impact, for papers by Sarah M. Labuda Breakdown of academic impact, for papers by Ayhan Yaman Breakdown of academic impact, for papers by C. Tulane
Rankless by CCL
2026